{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-099512","form_type":"8-K","ticker":"KROS","cik":"0001664710","company_name":"Keros Therapeutics, Inc.","filed_at":"2025-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.076971+00:00","generated_at":"2026-05-17T03:44:51.607656+00:00","sec_items":["1.01","2.02","8.01","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Keros repurchases $181M of stock from ADAR1 & Pontifax at $17.75; plans $194M tender offer","bullets":["Agreed to repurchase all shares held by ADAR1 (13.3%) and Pontifax (11.8%) at $17.75/share for ~$181M total.","Plans to commence tender offer by end of October 2025 for up to $194M of additional shares at $17.75/share.","Directors Tomer Kariv and Ran Nussbaum resigned from board; Jean-Jacques Bienaimé appointed Nominating Committee Chair.","Preliminary cash and cash equivalents as of Sept 30, 2025: ~$693.5M.","Will distribute 25% of any net proceeds from Takeda license agreement received by Dec 31, 2028 to stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-099512","json":"https://secwatch.observer/filing/0001104659-25-099512.json","markdown":"https://secwatch.observer/filing/0001104659-25-099512.md","text":"https://secwatch.observer/filing/0001104659-25-099512.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1664710/000110465925099512/0001104659-25-099512-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1664710/000110465925099512/tm2528773d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:44:51.607656+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}